Patent · US Active

Ingestible medical delivery devices

US11478431B2 · kind B2 · utility

0Cited by
16References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2020
Grant dateOct 25, 2022
Priority date—
Expiry dateNov 26, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61J3/072
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Exemplary embodiments of the disclosure may be drawn to ingestible delivery devices. An ingestible delivery device may include a first compartment and a second compartment. A lipase may be contained within the first compartment, and a fat may be contained within the second compartment. The first compartment may be sealed from the second compartment prior to exposure to a trigger, preventing the lipase and the fat from contacting each other, and at least one of the first compartment or the second compartment may at least partially rupture upon exposure to the trigger, allowing the lipase and the fat to contact each other.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.